Winner: Best Hospital 2020, LaingBuisson
The Royal Marsden Private Care won two awards for our services at the virtual LaingBuisson Awards 2020, for Private Public Partnership and Best Hospital.
The annual awards ceremony, which took place on Thursday 22 April 2021, recognises and celebrates excellence within healthcare industry and social care services public, private and third sectors.
Jointly with Cromwell Hospital, the Trust was also awarded the Private Public Partnership award for The Royal Marsden Surgical Cancer Hub – which operated on over 2,400 patients from across ten London Trusts over the past year.
The Royal Marsden Surgical Cancer Hub was designed to co-ordinate care at COVID-protected hospitals for the safe treatment of vulnerable cancer patients. Through partnering with independent sector providers, the hub has been essential in ensuring continuation of much needed care for hundreds of patients.
The main objectives of the partnership were to reduce NHS cancer surgery delays during the COVID-19 pandemic by enabling Royal Marsden surgeons to work at Cromwell Hospital; deliver time-critical NHS surgery during the COVID-19 pandemic for different types of cancer; and to create a unique private patient pathway during the COVID-19 pandemic for the continuation of care for both Royal Marsden and Cromwell Hospital patients.
The Best Hospital accolade was awarded for our world-leading cancer research. As Europe’s largest comprehensive cancer centre, The Royal Marsden treats over 60,000 patients each year, including more private cancer patients than any other UK centre. With an international reputation for pioneering the latest cancer treatments, The Royal Marsden is a global leader in cancer research.
Shams Maladwala, Managing Director, Private Care, said: “We are absolutely delighted to have won two prestigious awards, particularly during such a challenging year. These awards are a testament to our dedicated teams who have gone above and beyond to ensure the continuation of care for thousands of cancer patients throughout the pandemic, launching multiple research studies at unprecedented speed and enabling vital access to healthcare and complex surgeries.”
“We’re proud of our unique partnership that made The Cancer Hub a reality and of all the teams involved in making sure we could continue to make a national and global contribution to cancer research and treatment. I would like to thank them for all their hard work and commitment in improving the lives of cancer patients.”